Triple
T7168825
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Food and Drug Administration Amendments Act of 2007 |
E167140
|
entity |
| Predicate | shortName |
P43
|
FINISHED |
| Object | FDA Amendments Act of 2007 |
E167140
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA Amendments Act of 2007 | Statement: [Food and Drug Administration Amendments Act of 2007, shortName, FDA Amendments Act of 2007]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: FDA Amendments Act of 2007 Context triple: [Food and Drug Administration Amendments Act of 2007, shortName, FDA Amendments Act of 2007]
-
A.
Food and Drug Administration Amendments Act of 2007
chosen
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
-
B.
Food and Drug Administration Modernization Act of 1997
The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
-
C.
Food and Drug Administration Safety and Innovation Act of 2012
The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
-
D.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
E.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c68888c10c819095e0383020225758 |
completed | March 27, 2026, 1:39 p.m. |
| NER | Named-entity recognition | batch_69c6e85c606081909f76d76fc5b90bc8 |
completed | March 27, 2026, 8:28 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c7bf8766508190945a96f9536135ef |
completed | March 28, 2026, 11:46 a.m. |
Created at: March 27, 2026, 2:48 p.m.